Myelodysplastic syndrome (MDS) is a group of disorders characterized by the dysfunction of the bone marrow's ability to produce healthy blood cells. MDS can be a pre-leukemic condition, which means it can progress to a more severe form of cancer, such as acute myeloid leukemia (AML). The transformation from MDS to AML is a serious progression and is associated with a poorer prognosis. It is important to note that not all patients with MDS will develop AML, but the risk is significant, with approximately 30% of MDS patients eventually developing this aggressive form of leukemia. read more >>

Myelodysplastic syndrome (MDS) is a group of diseases that affects normal blood cell production in the bone marrow. In MDS, the bone marrow produces abnormal, immature blood cells called blast cells. ... About 30% of people with MDS will progress to a form of cancer called acute myeloid leukaemia (AML).read more >>